Cullen/Frost Bankers
PAHC icon

Cullen/Frost Bankers’s Phibro Animal Health PAHC Stock Holding History

Cullen/Frost Bankers’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.5K Buy
1,002
+102
+11% +$4.3K ﹤0.01% 976
2026
Q1 		$49.8K Buy
900
+125
+16% +$5.95K ﹤0.01% 798
2025
Q4 		$29K Buy
775
+170
+28% +$6.91K ﹤0.01% 913
2025
Q3 		$24.5K Buy
605
+12
+2% +$396 ﹤0.01% 901
2025
Q2 		$15.1K Buy
593
+428
+259% +$9.33K ﹤0.01% 968
2025
Q1 		$3.53K Buy
165
+25
+18% +$559 ﹤0.01% 1094
2024
Q4 		$2.93K Buy
+140
New +$3.24K ﹤0.01% 1090

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cullen/Frost Bankers's PAHC Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Phibro Animal Health (PAHC) stake by 11% in Q2 2026, buying an estimated $4.3K and bringing the position to 1,002 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #976.

Cullen/Frost Bankers first reported a position in PAHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $49.8K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Cullen/Frost Bankers held 1,002 shares of Phibro Animal Health worth $31.5K as of Q2 2026.
  • Cullen/Frost Bankers bought 102 Phibro Animal Health shares in Q2 2026, an estimated $4.3K.
  • Phibro Animal Health made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #976 holding.
  • Cullen/Frost Bankers first reported a position in Phibro Animal Health in Q4 2024 and has held it in 7 quarters since.
  • Cullen/Frost Bankers's Phibro Animal Health position peaked at $49.8K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.